Peptide

Pielotax

Also known as

Pielotax peptide · kidney bioregulator

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

What it is

Identity	A kidney-support bioregulator product, described in its report as A-9, a young-animal kidney peptide mixture rather than one defined synthetic molecule.
Forms and claims	Capsule and lingual products appear in discussion. Kidney-targeted describes the claim; it does not demonstrate exclusive delivery to kidneys or repair of damaged tissue.

Notes

People discuss Pielotax for kidney support. Favorable accounts involve other compounds, so they do not isolate its contribution. It has no dependable immediate feel or established community dose.

A-9: a kidney-tissue mixture. The report describes young-animal kidney peptides, rather than one defined synthetic molecule. Pielotax clinical report in institute product brochure (Official context · Accessed 2026-09-30)

Capsules and lingual products are separate forms. The existing identity is oral. A Reddit organ-repair discussion also mentions a lingual form, but supplies no comparison showing it works better than tablets. Capsule amounts cannot be carried over to drops. Peptides for organ repair (Community discussion · Accessed 2026-09-30)

Kidney-targeted describes the claim. Bioregulator discussion frames Pielotax as organ support rather than a growth-hormone peptide. Swallowing a capsule does not demonstrate that its contents travel exclusively to kidneys or rebuild damaged tissue. Про Пиелотакс (пептиды для почек) (Community discussion · Accessed 2026-09-30)

Source context — Pielotax clinical report in institute product brochure: Institute-affiliated commercial brochure, not independently verified peer-reviewed publication. Multiple brochure mirrors share one original source family. No clear blinding methods or independent replication supplied in this report; conventional therapy continued. Its no-side-effect/any-therapy assertions are not established safety or interaction guarantees.

Source context — Peptides for organ repair: Suggestion/question rather than comparative exposure. Deleted user's generic cycles and vendor links were not treated as specific Pielotax dosing or sourcing instructions.

Source context — Про Пиелотакс (пептиды для почек): Russian body read and paraphrased in English. Small historical exchange; no firsthand Pielotax outcome. Eye-product trial quoted by participants is not kidney evidence.

What people notice

Kidney-marker account	One Pielotax/astragalus user reported an estimate in the high 70s, then 99 after switching to a cystatin-C test. Different tests and co-use prevent concluding that filtration recovered.
Feel and nonresponse	No dependable immediate feeling is established. Broader bioregulator accounts describe subtle comfort or recovery; isolated Pielotax nonresponse and adverse outcomes are not characterized.

Notes

High 70s and 99 came from different tests. Randolfstcosmo described a standard eGFR in the high 70s, then a cystatin-C-based score of 99 after three months with astragalus and Pielotax. They suspected creatine and lifting influenced the first result. This is one account, not proof of restored filtration. Want to hear pielotax experience (Community discussion · Accessed 2026-09-30)

Different filtration estimates are not interchangeable. NIDDK explains that muscle mass and diet can affect creatinine-based estimates; cystatin C has its own influences. Switching markers can change the estimate without establishing a treatment effect. Clinical Measurements & eGFR Accuracy (Official context · Accessed 2026-09-30)

People discuss Pielotax for kidney support. Favorable accounts involve other compounds, so they do not isolate its contribution. It has no dependable immediate feel or established community dose.

Comfort or recovery can be subtle. Broader organ-bioregulator accounts describe mild support or recovery feelings that are difficult to separate from sleep and diet. They do not establish a characteristic Pielotax sensation, a reliable energy lift or kidney regeneration.

Nonresponse and adverse outcomes are not characterized. No isolated unchanged or adverse Pielotax outcome appears in these accounts. That absence cannot establish universal benefit or tolerability. Want to hear pielotax experience (Community discussion · Accessed 2026-09-30) · Pielotax: cost, client claim and clearance assertion (Secondhand community claim · Accessed 2026-09-30) · Peptides for organ repair (Community discussion · Accessed 2026-09-30)

Source context — Want to hear pielotax experience: One self-report involving astragalus, creatine/lifting concerns and a switch from standard eGFR to cystatin C. No verified labs, product, route, dose or isolated effect. Repeated comments are one account. Facebook praise is secondhand and inaccessible.

Source context — Clinical Measurements & eGFR Accuracy: General marker interpretation, not evidence that Pielotax changes kidney function. Both markers have non-filtration influences.

Source context — Pielotax: cost, client claim and clearance assertion: Client claim has no denominator or outcomes; route/form unstated. No linked study for seven-day clearance. Opened extract contains fewer replies than search result; later search-only comments were not used.

Doses people talk about

Diary fraction	One commercially linked diary says 1/4 capsule/day under a heading now naming Renolux. Product identity and a milligram equivalent remain uncertain.
Reddit claim	About 10–20 mg with suggested use 2–3 times weekly appears in a commenter’s client claim. Product, route and per-use versus daily total are unclear.
Retail strength	10 mg per capsule is a saved complex-strength figure. It does not establish daily intake or a kidney-treatment dose.

Notes

One diary: 1/4 capsule per day. Its commercially linked heading now names Renolux, leaving milligrams uncertain. We tried 40 peptides in 1 year – our reviews and top picks! (Personal report · Accessed 2026-09-30)

Liverra/Pielotax/Bone Marrow sections, lines 1298–1347; broader current stacks 1593–1628; commercial coupon section 1633–1643 and publication/update line 1697. We tried 40 peptides in 1 year – our reviews and top picks! (Personal report · Accessed 2026-09-30)

One Reddit claim: about 10–20 mg. A commenter citing clients suggests use 2–3 times weekly to reduce cost. Route and product are unspecified, and the comment does not clearly distinguish a per-administration amount from a daily total. Pielotax: cost, client claim and clearance assertion (Secondhand community claim · Accessed 2026-09-30)

Retail strength: 10 mg per capsule. This complex mass differs from the diary fraction and Reddit claim. Brand strength, daily intake and a kidney-treatment dose remain unestablished.

Source context — We tried 40 peptides in 1 year – our reviews and top picks!: Commercially linked self/caregiver diary. Pielotax heading now says Renolux; product identity across observations uncertain. Fraction has no verified mg equivalent. Skin-color report concerns daughter; dizziness report concerns author. Several co-agents; no objective Pielotax kidney outcome. Affiliate relationship preserved from frozen detail; opened body directly confirms coupons/purchase links.

Half-life, onset & duration

Felt onset	No dependable Pielotax-specific onset is established. A two-day skin-color report involved a kidney product plus Liverra with changing product identity; three months was a separate testing interval.
Felt duration	No reliable hours-per-dose or post-stop benefit window is recorded. Course length does not measure effect duration.
Half-life	Measured human half-life remains unknown. A seven-day clearance claim names no study or product and is not itself a half-life.

Notes

About two days in a combined-product diary. A caregiver saw changed skin color with Liverra plus a kidney product; attribution is uncertain. We tried 40 peptides in 1 year – our reviews and top picks! (Personal report · Accessed 2026-09-30)

Three months was a testing interval. The Reddit author tested then after Pielotax plus astragalus; no benefit start date was identified. Want to hear pielotax experience (Community discussion · Accessed 2026-09-30)

No dependable hours-per-dose benefit window. The reviewed accounts do not track a repeatable feeling from one dose to the next. A course length does not establish how long an effect persists.

Improvement after stopping is not established. The reviewed record supplies no measured post-stop benefit window.

Seven-day clearance is an unsupported circulated claim. The same Reddit commenter invokes unnamed single-dose studies. No study, tested product or population is identified. Seven days to clear the body is also not a half-life, which means the time for an amount to fall by half. Pielotax: cost, client claim and clearance assertion (Secondhand community claim · Accessed 2026-09-30)

A measured human Pielotax half-life remains unknown. Older bioregulator lore assumes rapid disappearance from blood and emphasizes courses. Neither that assumption nor a weekly calendar measures clearance of this orally sold mixture.

Cycles people discuss

Course discussions	Community discussion says 10–20 days; retail charts say 10–30 days repeated 2–3 times yearly. Neither establishes an effective schedule.
Repeats and breaks	One user intended roughly annual repetition, without documented repeats. Broader weeks-on/weeks-off discussion supplies no Pielotax-specific break interval.

Notes

Course talk has two origins. Community discussion says 10–20 days; retail charts say 10–30 days, repeated 2–3 times yearly. Neither establishes a schedule.

A Reddit user planned roughly annual repetition. That was an intention, not documented repetition. Their three-month testing wait was not a stated course. Want to hear pielotax experience (Community discussion · Accessed 2026-09-30)

Weeks on, weeks off also appears in broader discussion. Cost and caution feature in these calendars; indefinite daily use is not the only pattern. There is no established Pielotax-specific break interval or meal-time rule.

Stacks

Astragalus	The kidney-marker account also used astragalus, so it does not isolate Pielotax.
Other bioregulators	A diary involved Liverra and other organ products; a separate dizziness account included iron, vessel/bone-marrow products and vinpocetine. Changing kidney-product identity further limits conclusions.

Notes

Less dizziness was a stack result. Diary of Recovery describes iron, vessel and bone-marrow bioregulators, kidney product and vinpocetine together. Changing identity prevents isolation. We tried 40 peptides in 1 year – our reviews and top picks! (Personal report · Accessed 2026-09-30)

Watch for

Allergy and product quality	Saved discussion flags unknown impurities, allergy and poorly characterized long-term use. Mild-tolerability claims do not establish safety.
Product exclusions	The product report excludes pregnancy, breastfeeding and ingredient intolerance. It does not establish interaction safety.
Symptoms and kidney disease	Saved cautions call for medical care for severe allergic symptoms, chest pain, neurological changes or uncontrolled pressure/glucose. A support product does not replace kidney-disease assessment.

Notes

Allergy, preparation quality and long-term uncertainty matter. The original discussion flags unknown impurities, allergy and uncertain long-term use. Mild-tolerability claims do not establish safety; changing several compounds together makes unwanted effects hard to attribute.

Product guidance excludes three groups. Pregnancy, breastfeeding and ingredient intolerance. Tolerability claims do not establish interaction or long-term safety. Pielotax clinical report in institute product brochure (Official context · Accessed 2026-09-30)

Symptoms need medical assessment. Severe allergic symptoms, chest pain, neurological changes, or uncontrolled blood pressure or glucose need medical care. A kidney-support product is not a substitute for assessment of kidney disease.

Full notes

People discuss Pielotax for kidney support. Favorable accounts involve other compounds, so they do not isolate its contribution. It has no dependable immediate feel or established community dose.

What Pielotax actually is

A-9: a kidney-tissue mixture. The report describes young-animal kidney peptides, rather than one defined synthetic molecule. Official context
Capsules and lingual products are separate forms. The existing identity is oral. A Reddit organ-repair discussion also mentions a lingual form, but supplies no comparison showing it works better than tablets. Capsule amounts cannot be carried over to drops. Community Reddit r/Peptides
Kidney-targeted describes the claim. Bioregulator discussion frames Pielotax as organ support rather than a growth-hormone peptide. Swallowing a capsule does not demonstrate that its contents travel exclusively to kidneys or rebuild damaged tissue. Community Dr-Denisov dialysis forum

What people hope to get from it

Better kidney markers, especially around training. People ask about creatinine and eGFR, an estimate of kidney filtration. A favorable Pielotax/astragalus account switched tests, complicating the result. Reddit r/Biohackers
Comfort or recovery can be subtle. Broader organ-bioregulator accounts describe mild support or recovery feelings that are difficult to separate from sleep and diet. They do not establish a characteristic Pielotax sensation, a reliable energy lift or kidney regeneration. Community Community

Doses people discuss

One diary: 1/4 capsule per day. Its commercially linked heading now names Renolux, leaving milligrams uncertain. Personal report
One Reddit claim: about 10–20 mg. A commenter citing clients suggests use 2–3 times weekly to reduce cost. Route and product are unspecified, and the comment does not clearly distinguish a per-administration amount from a daily total. Reddit r/Biohackers
Retail strength: 10 mg per capsule. This complex mass differs from the diary fraction and Reddit claim. Brand strength, daily intake and a kidney-treatment dose remain unestablished. Community

Half-life and clearance talk

Seven-day clearance is an unsupported circulated claim. The same Reddit commenter invokes unnamed single-dose studies. No study, tested product or population is identified. Seven days to clear the body is also not a half-life, which means the time for an amount to fall by half. Reddit r/Biohackers
A measured human Pielotax half-life remains unknown. Older bioregulator lore assumes rapid disappearance from blood and emphasizes courses. Neither that assumption nor a weekly calendar measures clearance of this orally sold mixture. Community

When people notice changes

About two days in a combined-product diary. A caregiver saw changed skin color with Liverra plus a kidney product; attribution is uncertain. Personal report
Three months was a testing interval. The Reddit author tested then after Pielotax plus astragalus; no benefit start date was identified. Reddit r/Biohackers
No established first-week experience. The broader bioregulator record mentions early gut or mood changes with oral use. Those are general reports, not a Pielotax-specific pattern everyone should expect. Community

How long a change lasts

No dependable hours-per-dose benefit window. The reviewed accounts do not track a repeatable feeling from one dose to the next. A course length does not establish how long an effect persists. Community
Improvement after stopping is not established. The reviewed record supplies no measured post-stop benefit window. Community

Courses and time off

Course talk has two origins. Community discussion says 10–20 days; retail charts say 10–30 days, repeated 2–3 times yearly. Neither establishes a schedule. Community
A Reddit user planned roughly annual repetition. That was an intention, not documented repetition. Their three-month testing wait was not a stated course. Reddit r/Biohackers
Weeks on, weeks off also appears in broader discussion. Cost and caution feature in these calendars; indefinite daily use is not the only pattern. There is no established Pielotax-specific break interval or meal-time rule. Community Community

What deserves caution

Allergy, preparation quality and long-term uncertainty matter. The original discussion flags unknown impurities, allergy and uncertain long-term use. Mild-tolerability claims do not establish safety; changing several compounds together makes unwanted effects hard to attribute. Community
Product guidance excludes three groups. Pregnancy, breastfeeding and ingredient intolerance. Tolerability claims do not establish interaction or long-term safety. Official context
Symptoms need medical assessment. Severe allergic symptoms, chest pain, neurological changes, or uncontrolled blood pressure or glucose need medical care. A kidney-support product is not a substitute for assessment of kidney disease. Community

What the accounts actually add

High 70s and 99 came from different tests. Randolfstcosmo described a standard eGFR in the high 70s, then a cystatin-C-based score of 99 after three months with astragalus and Pielotax. They suspected creatine and lifting influenced the first result. This is one account, not proof of restored filtration. Reddit r/Biohackers
Less dizziness was a stack result. Diary of Recovery describes iron, vessel and bone-marrow bioregulators, kidney product and vinpocetine together. Changing identity prevents isolation. Personal report
Seller skepticism is a real disagreement. An Evolutionary.org poster with type 1 diabetes questioned Pielotax claims before trying it. Replies promoted other supplements; they did not supply a Pielotax outcome. The poster's description of it as a SARM was an identity mistake. Evolutionary.org
Regeneration explanations are disputed. On a Russian dialysis forum, a hopeful question prompted objections to the idea that swallowed peptides insert into cells and repair kidneys. The exchange supplies disagreement, not evidence from a Pielotax trial or an exposed user's recovery. Dr-Denisov dialysis forum
Nonresponse and adverse outcomes are not characterized. No isolated unchanged or adverse Pielotax outcome appears in these accounts. That absence cannot establish universal benefit or tolerability. Reddit r/Biohackers Reddit r/Biohackers Reddit r/Peptides Community

Context for interpreting the claims

Different filtration estimates are not interchangeable. NIDDK explains that muscle mass and diet can affect creatinine-based estimates; cystatin C has its own influences. Switching markers can change the estimate without establishing a treatment effect. Official context
An affiliated 2011 comparison. Among 42 gout-related kidney disease patients, 27 added Pielotax; 15 continued conventional therapy alone. Independent confirmation is lacking. Official context